Cetera Trust Company N.A Lowers Stake in Healthpeak Properties, Inc. (NYSE:DOC)

Cetera Trust Company N.A lowered its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 8.8% in the fourth quarter, Holdings Channel reports. The institutional investor owned 9,550 shares of the real estate investment trust’s stock after selling 925 shares during the period. Cetera Trust Company N.A’s holdings in Healthpeak Properties were worth $194,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the stock. State Street Corp purchased a new stake in Healthpeak Properties during the third quarter worth $1,093,576,000. JPMorgan Chase & Co. lifted its holdings in shares of Healthpeak Properties by 23.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock valued at $493,115,000 after purchasing an additional 4,056,931 shares during the last quarter. Geode Capital Management LLC purchased a new stake in shares of Healthpeak Properties during the 3rd quarter valued at $403,898,000. Charles Schwab Investment Management Inc. purchased a new stake in shares of Healthpeak Properties during the 3rd quarter valued at $230,988,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in shares of Healthpeak Properties during the 3rd quarter valued at $175,697,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Price Performance

Shares of DOC opened at $20.82 on Wednesday. The business’s 50-day moving average is $20.87 and its two-hundred day moving average is $21.53. The company has a market capitalization of $14.56 billion, a P/E ratio of 44.29, a P/E/G ratio of 2.24 and a beta of 1.14. The company has a debt-to-equity ratio of 0.93, a quick ratio of 1.31 and a current ratio of 1.31. Healthpeak Properties, Inc. has a fifty-two week low of $16.01 and a fifty-two week high of $23.26.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.44 by ($0.32). The company had revenue of $700.40 million for the quarter, compared to analyst estimates of $682.51 million. Healthpeak Properties had a return on equity of 3.53% and a net margin of 12.10%. Healthpeak Properties’s revenue for the quarter was up 25.9% on a year-over-year basis. During the same period in the prior year, the business posted $0.45 earnings per share. Research analysts predict that Healthpeak Properties, Inc. will post 1.81 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.76%. The ex-dividend date of this dividend was Monday, November 4th. Healthpeak Properties’s dividend payout ratio (DPR) is presently 255.32%.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on DOC shares. Morgan Stanley upgraded Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price objective for the company in a report on Wednesday, January 15th. Royal Bank of Canada increased their price objective on Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Robert W. Baird increased their price objective on Healthpeak Properties from $24.00 to $25.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. Deutsche Bank Aktiengesellschaft upgraded Healthpeak Properties from a “hold” rating to a “buy” rating and increased their price objective for the company from $20.00 to $28.00 in a report on Monday, October 21st. Finally, Wells Fargo & Company reduced their target price on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 10th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Healthpeak Properties has an average rating of “Moderate Buy” and a consensus price target of $24.15.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.